Fecal bacteriotherapy for ulcerative colitis: Patients are ready, are we?

Inflammatory Bowel Diseases

Volumn 18, Issue 4, 2012, Pages 676-684

  Kahn, Stacy A ^a   Gorawara Bhat, Rita ^a   Rubin, David T ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Complementary and alternative medicine; Ethical issues in IBD; Fecal bacteriotherapy; Focus groups; Microbiology of IBD; Ulcerative colitis

Indexed keywords

PROBIOTIC AGENT;

ADOLESCENT; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; ATTITUDE TO ILLNESS; CHILD; CLINICAL ARTICLE; COLITIS; FECAL BACTERIOTHERAPY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MICROBIOME; PARENT; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SCHOOL CHILD; STIGMA; TASTE AVERSION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; CHILD; COLITIS, ULCERATIVE; FECES; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PROBIOTICS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 80155204857     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21775     Document Type: Article

References (24)

1. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577-594. (Pubitemid 351173057)
2. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature. 2007;449:804-810. (Pubitemid 47598620)
3. Rubin DT, Siegel CA, Kane SV, et al. Impact of ulcerative colitis from patients' and physicians' perspectives: results from the UC: NORMAL survey. Inflamm Bowel Dis. 2009;15:581-588.
4. Quattropani C, Ausfeld B, Straumann A, et al. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes. Scand J Gastroenterol. 2003;38:277-282. (Pubitemid 36469987)
5. Markowitz JE, Mamula P, delRosario JF, et al. Patterns of complementary and alternative medicine use in a population of pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004; 10:599-605. (Pubitemid 39276468)
6. Wong AP, Clark AL, Garnett EA, et al. Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey. J Pediatr Gastroenterol Nutr. 2009;48:55-60.
7. Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44: 854-859.
8. Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet. 1989;1:164. (Pubitemid 19034066)
9. Borody TJ, Warren EF, Leis SM, et al. Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol. 2004;38: 475-483. (Pubitemid 38808419)
10. Borody TJ, Warren EF, Leis S, et al. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol. 2003;37:42-47. (Pubitemid 36734332)
11. Human Microbiome Project: Overview. 2011. Available at: http://com monfund.nih.gov/hmp/overview.aspx. Accessed February 9, 2011.
12. McGuire AL, Colgrove J, Whitney SN, et al. Ethical, legal, and social considerations in conducting the Human Microbiome Project. Genome Res. 2008;18:1861-1864.
13. Floch MH. Fecal bacteriotherapy, fecal transplant, and the microbiome. J Clin Gastroenterol. 2010;44:529-530.
14. Nair K, Dolovich L, Cassels A, et al. What patients want to know about their medications. Focus group study of patient and clinician perspectives. Can Fam Physician. 2002;48:104-110. (Pubitemid 34173190)
15. Baars JE, Markus T, Kuipers EJ, et al. Patients' preferences regarding shared decision-making in the treatment of inflammatory bowel disease: results from a patient-empowerment study. Digestion. 2010;81: 113-119.
16. Healed of ulcerative colitis within 24 hours: fecal flora replacement protocol. 2005. Available at: http://curezone.com/forums/fm.asp?i=57263#i. Accessed February 9, 2011.
17. Fecal bacteriotherapy-human probiotic infusion-ulcerative colitis. 2009. Available at: http://www.topix.com/forum/health/colitis/TA5A NBB43CD9AP8NP. Accessed February 9, 2011.
18. Fecal transplant - I took the plunge! PART III. 2009. Available at: http://www.healingwell.com/community/default.aspx?f=38&m=1662417&p=5. Accessed February 9, 2011.
19. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003;36:580-585. (Pubitemid 36259562)
20. Silverman MS, Davis I, Pillai DR. Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clin Gastroenterol Hepatol. 2010;8:471-473.
21. Yoon SS, Brandt LJ. Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients. J Clin Gastroenterol. 2010;44:562-566.
22. Grehan MJ, Borody TJ, Leis SM, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol. 2010;44:551-561.
23. Khoruts A, Dicksved J, Jansson JK, et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol. 2010; 44:354-360.
24. Langhorst J, Anthonisen IB, Steder-Neukamm U, et al. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey. Inflamm Bowel Dis. 2005;11:287-295. (Pubitemid 40439683)